Ventra

Ventra

Biotechnologieforschung

Preventing babies' allergies and autoimmune diseases by analysing their microbiome and providing precision synbiotics

Info

We are on a mission to unlock the potential of microbiome data analysis to reduce the risk for babies to suffer from allergies and other chronic diseases. We analyze babies' intestinal microbiomes (gut flora) to understand whether they are missing specific gut microbes essential for imprinting the immune system during our first 1000 days in life. Studies have shown, that babies that are missing these microbes have a higher risk of suffering from allergies, autoimmune diseases, obesity, and even psychological disorders later in life. Especially babies born via c-section, with antibiotic medication, or without mothers' milk have been shown to be missing these essential gut bacteria. If babies are missing important gut microbes, we provide personalized synbiotics (a combination of pro- and prebiotics) tailored to their age and diet.

Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Munich
Art
Privatunternehmen
Gegründet
2022
Spezialgebiete
microbiome, baby health, synbiotics, next generation sequencing, gut health, preventive health care und machine learning

Orte

Beschäftigte von Ventra

Updates

Ähnliche Seiten

Finanzierung